AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.…
AptarGroup (ATR) Lifts Its Dividend Following Earnings, Is It Still 11% Below Fair Value?
AptarGroup (NYSE: ATR) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 14,000 employees.
The shares were at 140.08 USD on 20 November 2026, up 18.3% over 52 weeks. Its 52-week range is 110.95 USD to 148.63 USD: the price is 5.8% below the high and 26.3% above the low.
At a market capitalisation of 8.88B USD, it trades at 33.8 times trailing earnings and 22.6 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 48.3, a discount of 30% for ATR. It pays a dividend yielding 1.43% (it pays out 46% of its earnings), against a median of 0.92% among the dividend payers in that peer group.
AptarGroup reports return on equity of 14.7%, an operating margin of 12.4% and revenue up 6.0% year over year.
Its debt exceeds its cash by 1.21B USD, a debt-to-equity ratio of 0.57. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 8 analysts cover the stock; their mean price target of 163.88 USD is 17.0% above the current price. The next earnings report is expected on 4 February 2027.